The Magnesium Glycinate 200 mg/ml Transdermal Gel is a semisolid formulation designed for topical application. This gel is dispensed through a user-friendly pump mechanism, ensuring consistent and accurate dosing with each use. The gel's consistency allows for smooth application and rapid absorption of magnesium glycinate through the skin. This transdermal delivery system is particularly beneficial for patients seeking targeted treatment for conditions such as magnesium deficiency, muscle cramps, and restless leg syndrome. Additionally, it may aid in the management of stress and anxiety, as magnesium plays a crucial role in neuromuscular transmission and muscle relaxation.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Magnesium Glycinate 200 mg/ml Transdermal Gel is a specially compounded semisolid formulation designed for ease of use and targeted delivery of magnesium through the skin. The gel is dispensed through a pump mechanism, which ensures that patients can apply a precise dose with each use. This method of application is particularly beneficial for those who may have difficulties with oral supplementation or for whom targeted treatment is recommended.
The transdermal delivery system allows for the magnesium to be absorbed directly into the bloodstream, bypassing the gastrointestinal tract, which can be advantageous for patients with digestive issues or for those who require a rapid onset of action. Magnesium, as an essential mineral, plays a pivotal role in numerous physiological processes, including muscle and nerve function, blood glucose control, and blood pressure regulation. It is also critical for the production of energy and protein synthesis.
Magnesium Glycinate is a chelated form of magnesium, which means it is bound to the amino acid glycine. This chelation enhances the absorption of magnesium and makes it more bioavailable than other forms. It is also less likely to cause gastrointestinal discomfort, a common side effect of other magnesium compounds. The 200 mg/ml concentration allows for customizable dosing based on the patient's specific needs and physician's recommendations.
This transdermal gel formulation can be used to treat or manage a variety of disease states. It is often prescribed for conditions associated with magnesium deficiency, such as muscle cramps, fibromyalgia, and chronic pain. It may also be beneficial for patients with conditions like hypertension, migraines, and osteoporosis, as well as for those undergoing stress or suffering from sleep disorders. Additionally, it can support cardiovascular health and has been used in the management of mild to moderate anxiety and depression.
Patients should be monitored for signs of magnesium overdose, such as diarrhea, nausea, and abdominal cramping, although these are less likely with transdermal application compared to oral supplementation. As with any medication, adherence to prescribed dosing and consultation with a healthcare provider is crucial for safety and efficacy.
For more detailed information on the use of Magnesium Glycinate 200 mg/ml Transdermal Gel, or to discuss whether this formulation is appropriate for your specific needs, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is committed to providing personalized care and is available to answer any questions you may have.
Magnesium glycinate is a form of magnesium that is often used for its calming effects on the nervous system and its ability to improve sleep quality, manage stress, and support muscle function. When formulated as a 200 mg/ml transdermal gel, it is designed to be absorbed through the skin, potentially offering an alternative route for those who may experience gastrointestinal discomfort with oral magnesium supplements. However, it is important to consider potential drug interactions when using this formulation.
Transdermal magnesium can interact with certain medications, although the extent of these interactions may be less pronounced than with oral forms due to the different absorption pathway. Bisphosphonates, used to treat osteoporosis, should be used cautiously with magnesium as it can interfere with the absorption of bisphosphonates if taken orally. While the transdermal route may reduce this risk, it is still advisable to monitor therapy closely. Similarly, magnesium can bind with certain antibiotics, particularly tetracyclines and quinolones, potentially reducing their effectiveness. Even though the transdermal route may bypass the gastrointestinal tract, it is recommended to separate the application of the gel from the administration of these antibiotics by at least a couple of hours.
Patients on medications for high blood pressure or muscle relaxants should also be aware that magnesium can potentiate the effects of these drugs, leading to an increased risk of side effects such as hypotension or excessive muscle relaxation. Diuretics, particularly loop and thiazide diuretics, can alter magnesium levels in the body, and the use of a transdermal magnesium gel may require monitoring of magnesium levels to avoid imbalances. Additionally, medications that lower stomach acid, such as proton pump inhibitors (PPIs) or H2 blockers, can affect magnesium absorption orally, but this is less of a concern with transdermal application.
For patients with kidney disease, caution is advised when using magnesium-containing products, including transdermal formulations, as impaired kidney function can lead to an accumulation of magnesium, potentially resulting in toxicity. It is essential to consult with a healthcare provider before starting transdermal magnesium therapy in this patient population.
Lastly, magnesium may also affect blood sugar control and could interact with insulin and other diabetes medications. Patients with diabetes should monitor their blood sugar levels closely when starting transdermal magnesium therapy and adjust their medication as necessary under the guidance of their healthcare provider.
It is important for both patients and prescribers to be aware of these potential interactions and to monitor for any signs of adverse effects or changes in the efficacy of concomitant medications. If you have any questions or concerns regarding the use of Magnesium Glycinate 200 mg/ml Transdermal Gel, or if you require more detailed information about specific drug interactions, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide support and guidance to ensure appropriate treatment.
The Magnesium Glycinate 200 mg/ml Transdermal Gel is a specially designed medication that delivers magnesium directly through the skin, bypassing the digestive system. This is particularly beneficial for individuals who may have difficulties with oral supplementation or for those who require targeted delivery of magnesium to specific areas of the body. The gel is formulated to have an appropriate consistency that allows it to be easily dispensed from a pump mechanism, ensuring a uniform and precise dose with each application.
The transdermal delivery system works by penetrating the outer layers of the skin, allowing the active ingredient, magnesium glycinate, to be absorbed into the bloodstream. Magnesium glycinate is a chelated form of magnesium, which means that the magnesium ion is bound to the amino acid glycine. This chelation process enhances the absorption of magnesium through the skin and makes it more bioavailable to the body's cells. Once absorbed, magnesium plays a crucial role in over 300 enzymatic reactions, including protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation.
In terms of treating disease states, magnesium is known to be beneficial in conditions such as muscle cramps, restless leg syndrome, fibromyalgia, and certain types of headaches. It can also have a calming effect on the nervous system, which may help with sleep disturbances and anxiety. Additionally, magnesium has been shown to improve cardiovascular health by reducing hypertension and has been used in the management of preeclampsia and eclampsia in pregnant women. The transdermal route of administration can be particularly useful for patients who require a steady release of magnesium throughout the day or for those who have localized muscle or nerve pain, as the gel can be applied directly to the affected area.
Patients with kidney disease or those taking certain medications should consult with their healthcare provider before using this formulation, as magnesium can interact with various drugs and conditions. Additionally, the optimal dose and frequency of application will vary depending on the individual's needs and the specific condition being treated.
For best results, the gel should be applied to clean, dry skin, and massaged gently until fully absorbed. Areas with thinner skin, such as the inner wrists or behind the knees, can facilitate better absorption. The use of the gel should be consistent, and it may take some time before the full benefits are observed. If you have any questions or require further information about the Magnesium Glycinate 200 mg/ml Transdermal Gel, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to support you with your healthcare needs.
Magnesium Glycinate 200 mg/ml Transdermal Gel is a semisolid medication specifically designed for application on the skin. It contains magnesium in the form of magnesium glycinate, which is often used for its calming and muscle-relaxant properties. The gel's unique formulation allows for the targeted treatment and direct absorption of the active ingredient through the skin.
The gel is dispensed through a pump mechanism to ensure easy and precise application. To use it, simply press the pump to dispense the recommended amount of gel and apply it gently to the area of skin as directed by your healthcare provider. The area of application will typically depend on the condition being treated.
The frequency of application will depend on individual medical advice and the condition being treated. Always follow the dosing instructions provided by your healthcare provider or the directions on the prescription label.
Unless instructed otherwise by your healthcare provider, the gel can be applied to areas of the body where the skin is clean and intact. Common application sites include the wrists, arms, legs, or the soles of the feet. Avoid areas with cuts, wounds, or irritation.
Magnesium is often used for its muscle-relaxant effects, and while the Magnesium Glycinate Transdermal Gel might offer relief from muscle pain, it is important to first consult with your healthcare provider to determine if this medication is appropriate for your specific situation.
While transdermal magnesium is generally well tolerated, it may not be suitable for everyone. People with kidney disease, sensitive skin, or specific allergies should consult with a healthcare professional before use. Additionally, if you are pregnant or breastfeeding, you should discuss with your doctor before starting any new medication.
As with any medication, there can be side effects. Common side effects may include mild itching or irritation at the application site. If you experience any severe reactions or signs of an allergic reaction, discontinue use immediately and seek medical attention.
If you miss a dose of your gel, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not apply extra gel to make up for a missed dose.
The onset of action will vary depending on various factors, including the individual's skin type, the condition being treated, and the application site. Some people may notice effects shortly after application, whereas for others, it may take longer. Consult with your healthcare provider for more detailed information.
Yes, you can wear clothes over the area, but it is advised to let the gel dry completely before dressing to prevent any transfer of the medication to your clothing. Loose-fitting clothing is ideal to avoid rubbing off the gel.
Store the gel at room temperature, away from heat and direct sunlight. Keep the container closed tightly when not in use. Make sure the medication is kept out of reach of children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)